Previous research, done by the same laboratory, also classifies LCN2 as a tumor suppressor since is seems to diminish proliferation and invasion of HCC cells through the blockade of JNK and PI3K/AKT signaling. This evidence concerns the gene LCN2 and hepatocellular carcinoma.